Prevalence of Statin Use and Predictors of Statin Initiation Among Patients with Alcohol-Related Cirrhosis - A Danish Nationwide Cohort Study

References

• Jepsen P, Vilstrup H, Sørensen HT. Alcoholic cirrhosis in Denmark - population-based incidence, prevalence, and hospitalization rates between 1988 and 2005: a descriptive cohort study. BMC Gastroenterol. 2008;8:3. doi:10.1186/1471-230x-8-3
   PubMed Web of Science ®Google Scholar
• Jepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010;51(5):1675–1682. doi:10.1002/hep.23500
   PubMed Web of Science ®Google Scholar
• Liao JK, Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89–118. doi:10.1146/annurev.pharmtox.45.120403.095748
   PubMed Web of Science ®Google Scholar
• Bays H, Cohen DE, Chalasani N, Harrison SA. The National Lipid Association’s Statin Safety Task F. An assessment by the Statin Liver Safety Task Force: 2014 update. J Clin Lipidol. 2014;8(3Suppl):S47–57. doi:10.1016/j.jacl.2014.02.011
   PubMedGoogle Scholar
• Naci H, Brugts JJ, Fleurence R, Tsoi B, Toor H, Ades AE. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials. Eur J Prev Cardiol. 2013;20(4):641–657. doi:10.1177/2047487313480435
   PubMed Web of Science ®Google Scholar
• Abraldes JG, Villanueva C, Aracil C, et al. Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis. Gastroenterology. 2016;150(5):1160–1170.e3. doi:10.1053/j.gastro.2016.01.004
   PubMed Web of Science ®Google Scholar
• Abraldes JG, Albillos A, Bañares R, et al. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology. 2009;136(5):1651–1658. doi:10.1053/j.gastro.2009.01.043
   PubMed Web of Science ®Google Scholar
• Pollo-Flores P, Soldan M, Santos UC, et al. Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: a randomized controlled trial. Dig Liver Dis. 2015;47(11):957–963. doi:10.1016/j.dld.2015.07.156
   PubMedGoogle Scholar
• Bishnu S, Ahammed SM, Sarkar A, et al. Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study. Eur J Gastroenterol Hepatol. 2018;30(1):54–59. doi:10.1097/meg.0000000000001006
   PubMed Web of Science ®Google Scholar
• Kumar S, Grace ND, Qamar AA. Statin use in patients with cirrhosis: a retrospective cohort study. Dig Dis Sci. 2014;59(8):1958–1965. doi:10.1007/s10620-014-3179-2
   PubMed Web of Science ®Google Scholar
• Bang UC, Benfield T, Bendtsen F. Reduced risk of decompensation and death associated with use of statins in patients with alcoholic cirrhosis. A nationwide case-cohort study. Aliment Pharmacol Ther. 2017;46(7):673–680. doi:10.1111/apt.14243
   PubMed Web of Science ®Google Scholar
• Chang FM, Wang YP, Lang HC, et al. Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: a population-based study. Hepatology. 2017;66(3):896–907. doi:10.1002/hep.29172
   PubMed Web of Science ®Google Scholar
• Mohanty A, Tate JP, Garcia-Tsao G. Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis. Gastroenterology. 2016;150(2):430–40.e1. doi:10.1053/j.gastro.2015.10.007
   PubMed Web of Science ®Google Scholar
• Henson JB, Patel YA, Muir AJ. Trends in statin utilisation in US adults with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2021;54(11–12):1481–1489. doi:10.1111/apt.16646
   PubMed Web of Science ®Google Scholar
• Thomsen RW, Johnsen SP, Olesen AV, et al. Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol. 2005;60(5):534–542. doi:10.1111/j.1365-2125.2005.02494.x
   PubMed Web of Science ®Google Scholar
• Carlsson AC, Wändell P, Gasevic D, Sundquist J, Sundquist K. Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care. Int J Cardiol. 2015;187:547–552. doi:10.1016/j.ijcard.2015.04.005
   PubMed Web of Science ®Google Scholar
• Erickson SR, Bravo M, Tootoo J. Geosocial Factors Associated With Adherence to Statin Medications. Ann Pharmacother. 2020;54(12):1194–1202. doi:10.1177/1060028020934879
   PubMed Web of Science ®Google Scholar
• Aarnio E, Martikainen J, Winn AN, Huupponen R, Vahtera J, Korhonen MJ. Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: does Sex Matter? Circ Cardiovasc Qual Outcomes. 2016;9(6):704–713. doi:10.1161/circoutcomes.116.002728
   PubMed Web of Science ®Google Scholar
• Jepsen P, Vilstrup H, Andersen PK, Sørensen HT. Socioeconomic status and survival of cirrhosis patients: a Danish nationwide cohort study. BMC Gastroenterol. 2009;9:35. doi:10.1186/1471-230x-9-35
   PubMed Web of Science ®Google Scholar
• Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7 Suppl):38–41. doi:10.1177/1403494810394717
   PubMed Web of Science ®Google Scholar
• Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53(4):441–449.
   PubMed Web of Science ®Google Scholar
• Randomised trial of cholesterol lowering in. 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344(8934):1383–1389.
   PubMed Web of Science ®Google Scholar
• Sundhedsstyrelsen. Viden om forbrug og bivirkninger ved behandling med statiner; 2012.
   Google Scholar
• Hernán MA, Hsu J, Healy B, Second A. Chance to Get Causal Inference Right: a Classification of Data Science Tasks. CHANCE. 2019;32(1):42–49. doi:10.1080/09332480.2019.1579578
   Google Scholar
• Wallach Kildemoes H, Toft Sørensen H, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7_suppl):38–41. doi:10.1177/1403494810394717
   PubMed Web of Science ®Google Scholar
• Petersson F, Baadsgaard M, Thygesen LC. Danish registers on personal labour market affiliation. Scand J Public Health. 2011;39(7 Suppl):95–98. doi:10.1177/1403494811408483
   PubMed Web of Science ®Google Scholar
• Jensen VM, Rasmussen AW. Danish Education Registers. Scand J Public Health. 2011;39(7Suppl):91–94. doi:10.1177/1403494810394715
   PubMedGoogle Scholar
• Vestberg K, Thulstrup AM, Sørensen HT, Ottesen P, Sabroe S, Vilstrup H. Data quality of administratively collected hospital discharge data for liver cirrhosis epidemiology. J Med Syst. 1997;21(1):11–20.
   PubMedGoogle Scholar
• Mahmud N, Chapin S, Goldberg DS, Reddy KR, Taddei TH, Kaplan DE. Statin exposure is associated with reduced development of acute-on-chronic liver failure in a Veterans Affairs cohort. J Hepatol. 2022;76(5):1100–1108. doi:10.1016/j.jhep.2021.12.034
   PubMed Web of Science ®Google Scholar
• Carstensen B, Rønn PF, Jørgensen ME. Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996-2016. BMJ Open Diabetes Res Care. 2020;8(1):e001071. doi:10.1136/bmjdrc-2019-001071
   PubMed Web of Science ®Google Scholar
• Traub J, Reiss L, Aliwa B, Stadlbauer V. Malnutrition in Patients with Liver Cirrhosis. Nutrients. 2021;13(2):540. doi:10.3390/nu13020540
   PubMed Web of Science ®Google Scholar
• Askgaard G, Fleming KM, Crooks C, et al. Socioeconomic inequalities in the incidence of alcohol-related liver disease: a nationwide Danish study. Lancet Reg Health Eur. 2021;8:100172. doi:10.1016/j.lanepe.2021.100172
   PubMedGoogle Scholar
• Forsberg P-O, Li X, Sundquist K. Neighborhood socioeconomic characteristics and statin medication in patients with myocardial infarction: a Swedish nationwide follow-up study. BMC Cardiovasc Disord. 2016;16(1):146. doi:10.1186/s12872-016-0319-y
   PubMedGoogle Scholar
• Adedinsewo D, Taka N, Agasthi P, Sachdeva R, Rust G, Onwuanyi A. Prevalence and factors associated with statin use among a nationally representative sample of us adults: national health and nutrition examination survey, 2011-2012. Clin Cardiol. 2016;39(9):491–496. doi:10.1002/clc.22577
   PubMed Web of Science ®Google Scholar
• Thompson W, Jarbøl DE, Nielsen JB, Haastrup P, Pottegård A. Statin use and discontinuation in Danes age 70 and older: a nationwide drug utilisation study. Age Ageing. 2021;50(2):554–558. doi:10.1093/ageing/afaa160
   PubMed Web of Science ®Google Scholar